Health & Medicine Week
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Health & Medicine Week
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Antibiotic Resistance
New reporting for resistant Streptococcus causes artificial case decline
March 22nd, 2004
State and local health officials who conduct surveillance for drug-resistant Streptococcus pneumoniae should understand that the new clinical-syndrome based National Committee for Clinical Laboratory Standards (NCCLS) breakpoints for defining susceptibility of S. pneumoniae to cefotaxime and ceftriaxone will cause a large artificial decline in the percentage of nonsusceptible isolates on surveillance reports, according to the U.S. Centers for Disease Control and Prevention (CDC). In January 2003, NCCLS finalized new breakpoints for defining the susceptibility of S. pneumoniae isolates to cefotaxime and ceftriaxone according to clinical syndrome. The...
Source: Health & Medicine Week (2004-03-22)
|
